Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Combined Modality Therapy × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Laryngeal Diseases 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Adenoid Cystic 1 Breast Neoplasms 1 Advanced or Metastatic Solid Tumors 1

Interventions

Bevacizumab 70 atezolizumab 56 lenvatinib 41 durvalumab 40 pembrolizumab 35 Nivolumab 34 tremelimumab 26 Magnetic Resonance Spectroscopy 21 Specimen Handling 19 tislelizumab 18 Ipilimumab 15 regorafenib 14 Sorafenib 14 sintilimab 13 cabozantinib 12 Radiosurgery 12 Radiotherapy 11 apatinib 10 Immunoglobulin G 10 Immune Checkpoint Inhibitors 10 Disulfides 9 Blood Specimen Collection 9 camrelizumab 8 X-Rays 8 Cyclophosphamide 8 Oxaliplatin 6 Immunotherapy 6 Hepatectomy 6 Fluorouracil 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡